In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Please provide your email address to receive an email when new articles are posted on . An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes ...
MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...
May 27, 2005-- Guidant Corporation (Indianapolis, Indiana) sent a letter to physicians this week informing them about a potential shorting defect in certain models of the company's PRIZM 2 DR ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.
ST. PAUL, Minn. St. Jude Medical, Inc. today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and the launch of the Fortify(TM) ST implantable cardioverter ...
(RTTNews) - Abbott (ABT) announced that the U.S. FDA has approved the company's next-generation Gallant implantable cardioverter defibrillator or ICD and cardiac resynchronization therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results